IMMUNOGLOBULIN IGG1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL DISULFIDE SCT400 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCT400 .KAPPA.-CHAIN, DIMER

Diffuse Large B Cell Lymphoma

Sinocelltech Ltd.monoclonal_antibodyPhase 3Dormant

CCC

54/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 45/ 100
Competitive Position: 73/ 100

Competitive context

271 Active assets in the Diffuse Large B Cell Lymphoma cohort.

Asset / Sponsor	Phase	Rating
VINCRISTINE SULFATE National Cancer Institute (NCI)	Phase 2/3	A
Evomela Ruijin Hospital	Phase 4	BBB
Axicabtagene Ciloleucel Ruijin Hospital	Phase 4	BBB
Inno-206 Beth Israel Deaconess Medical Center	Phase 4	BBB
PREDNISONE TABLETS Beth Israel Deaconess Medical Center	Phase 4	BBB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN IGG1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL DISULFIDE SCT400 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCT400 .KAPPA.-CHAIN, DIMER is also rated in:

B-cell non-Hodgkin lymphomaDormant

CCC

Indicative ·

53 / 100

View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →